From rapid prototyping, data analysis and software development, to regulatory affairs and entrepreneurship, our staff expertise enables neuroscience innovation to reach the patient.
Quality assurance, clinical and regulatory affairs
Business development and intellectual property
Our state-of-the art facilities at Campus Biotech in Geneva house world-class translational research and support our collaborative efforts with academia and industry. Complementing our portfolio are pre-clinical and clinical platforms available at Campus Biotech and at our collaborating academic institutions and hospitals.
State-of-the-art advanced lightsheet imaging center
Advanced electrical and mechanical engineering design and fabrication
As part of the rich collaborative environment at Campus Biotech, state-of-the-art multi-user platforms - the Neural Microsystems Platform (NMP), the Preclinical Neuroscience Platform (PNP) and the Human Neuroscience Platform (HNP) - make a substantial contribution to the innovative capabilities of the Campus.
The Wyss Center announces CE mark for its brain-computer interface software for communication, NeuroKey BCI
NeuroKey BCI enables people who are completely locked-in to communicate in real time.Technology
Epios™ selected for MassChallenge Switzerland 2021 accelerator
The Wyss Center’s spin-off company Epios joins a global network of entrepreneurs with its long-term brain monitoring technology.Technology
2nd EPFL-Wyss Center call for entrepreneurial projects
Are you developing a promising technology in the field of applied neuroscience or neurotechnology? Do you intend to bring it to the market? This joint EPFL-Wyss Center call for projects might be for you.Collaboration